Home › Studies › PRJNA800792
PRJNA800792 SRP356883

Ex vivo synthetic glycan fermentation of US stool samples

An ex vivo screening of selected glycans across multiple individuals

154 stool samples from healthy individuals in the USA were treated ex vivo with 3 glycans for 45 hours under anaerobic conditions in Mega Medium, in an intervention study. machine-written summary

154 samples · 154 runs · US · Age unknown · 2022 · 0.23 Gbp / sample

Sources
✓Sequence archive 984✓Abstract / description 278○Full text○Supplementary tables–External resources–User contribution–Human verified

Checked this project's papers and archive records yourself? Mark it human-verified.

what each source gave
✓ Sequence archive984 sample values (collection date, country, health condition, intervention, latitude, longitude, medication, medication detail)
✓ Abstract / description278 sample values (health condition, health condition detail)
○ Full textread; no usable statement or table · PMC8913648
○ Supplementary tablesfiles read; no table could be matched to the samples
– External resourcesnot covered by the external resources we ingest
– User contributionnothing uploaded yet
– Human verifiednot yet checked by a person · I checked this project — verify it
Samples at a glance
1 sampling locations · 1 country
Age
unknown154
Condition
healthy_control154
Country
US154
Body site
primary154
Sequencing depth per sample · this project all projects
all projects, 0–0.03 Gbp: 25,080 samples (4 %)this project, 0–0.03 Gbp: 3 samplesall projects, 0.03–0.1 Gbp: 17,066 samples (3 %)this project, 0.03–0.1 Gbp: 18 samplesall projects, 0.1–0.3 Gbp: 29,179 samples (5 %)this project, 0.1–0.3 Gbp: 84 samplesall projects, 0.3–1 Gbp: 47,044 samples (8 %)this project, 0.3–1 Gbp: 49 samplesall projects, 1–3 Gbp: 124,983 samples (22 %)all projects, 3–10 Gbp: 253,728 samples (44 %)all projects, 10–30 Gbp: 72,533 samples (13 %)all projects, 30–100 Gbp: 3,024 samples (1 %)all projects, 100–300 Gbp: 106 samples (0 %)all projects, ≥ 300 Gbp: 9 samples (0 %)project median 0.23 Gbp per sample0130Gbp
Sampling design and relatedness

longitudinal — not resolved

26 of 26 people sampled more than once (154 samples; median 6, up to 6 per person).

How longitudinal and relatedness information is derived

Community composition
Bacteroides 17.7%Parabacteroides 9.6%Escherichia 7.7%Faecalibacterium 5.5%Peptoniphilus_A 3.7%Dorea_A 3.2%Bifidobacterium 3.2%Phocaeicola 2.9%Otoolea 2.1%Streptococcus 2.1%Hominenteromicrobium 2.0%Enterococcus_B 1.7%not assigned to a genus 18.4%other genera 20.2%

Genera, mean relative abundance over 118 profiled gut samples of this project (Sandpiper SingleM profiles, GTDB R232; low-depth and non-metagenome profiles left out).

Field coverage
fieldsamplescoverageR1R2R3R4
age_category0 0%
country154 100%154
health_condition154 100%30124
subject_id154 100%154
collection_date154 100%154
health_condition_detail154 100%154
intervention154 100%154
latitude154 100%154
longitude154 100%154
medication15 10%15
medication_detail15 10%15
Papers (1)
  • Synthetic glycans control gut microbiome structure and mitigate colitis in mice. 2022 PMID 35273143 PMC8913648 own_data
Details
Archive description

3 glycans across multiple healthy human stool samples treated ex vivo for 45 hours under anaerobic conditions in Mega Medium and sequenced

How this project entered the registry

Classified as human gut / stool shotgun DNA metagenome of age unknown by sonnet_x2 with confidence 0.60. Assay shotgun_dna.

  • host run.scientific_name · “human gut metagenome”
  • body site study.description · “healthy human stool samples treated ex vivo”
Evidence examples (one per field × route)
samplefieldvaluerouteconf.sourcequote
SAMN25283235collection_date2018-07-07R10.90biosample.attribute:collection_date2018-07-07
SAMN25283235countryUSR10.90sample.attr.geo_loc_nameUSA
SAMN25283259health_conditionhealthy_controlR10.90biosample_attrLactulose
SAMN25283235health_conditionhealthy_controlR40.50study.descriptionhealthy human stool samples
SAMN25283235health_condition_detailHealthy individuals; ex vivo screening studyR40.50study.descriptionhealthy human stool samples
SAMN25283235interventionprebiotic_or_fibreR10.85biosample.attribute:treatmentBQM
SAMN25283235latitude38.0400R10.90biosample.attribute:lat_lon38.04 N 84.50 W
SAMN25283235longitude-84.5000R10.90biosample.attribute:lat_lon38.04 N 84.50 W
SAMN25283259medicationlaxativeR10.90biosample.attribute:treatmentLactulose
SAMN25283259medication_detailLactuloseR10.90biosample.attribute:treatmentLactulose
SAMN25283235subject_id801-003R10.85sample.attr.subject_id801-003
Sequencing

154 runs over 154 samples · mean 0.23 Gbp per run (median 0.23 Gbp, total 35.35 Gbp; 154 runs with a base count) · layout SINGLE 154 · platform ILLUMINA 154 · models HiSeq X Ten (154) · 77% of runs with a Sandpiper profile · first public 2022-02-02

Authors (17)

Tolonen AC first · Beauchemin N · Bayne C · Li L · Tan J · Lee J · Meehan BM · Meisner J · Millet Y · LeBlanc G · Kottler R · Rapp E · Murphy C · Turnbaugh PJ · von Maltzahn G · Liu CM · van Hylckama Vlieg JET last

Downloads

PRJNA800792.csv.gz (4.2 KB) · parquet (75.8 KB) — all 154 samples, every field with route and confidence · PRJNA800792_determinations.csv.gz (7.6 KB) — 1,262 evidence rows

Samples (154 · every field this project has values for · hover a cell for its source)
Loading the sample table…